Literature DB >> 5652711

Desferrioxamine in thalassaemia.

M Diwany, M Gabr, A el Hefni, N Mokhtar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5652711      PMCID: PMC2019950          DOI: 10.1136/adc.43.229.340

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  6 in total

1.  THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE.

Authors:  F WOEHLER
Journal:  Acta Haematol       Date:  1963-08       Impact factor: 2.195

2.  Metabolism of the chelating agent diethylenetriamine pentaacetic acid (C14DTPA) in man.

Authors:  E STEVENS; B ROSOFF; M WEINER; H SPENCER
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

3.  Influence of desferrioxamine on the renal excretion of iron. Preliminary report.

Authors:  J B NIELSEN
Journal:  Acta Med Scand       Date:  1963-04

4.  Effect of Desferrioxamine and D.T.P.A. in Iron Overload.

Authors:  R M Bannerman; S T Callender; D L Williams
Journal:  Br Med J       Date:  1962-12-15

5.  ACUTE IRON INTOXICATION. TREATMENT WITH DESFERRIOXAMINE (BA-29837).

Authors:  A S SANTOS; A V PISCIOTTA
Journal:  Am J Dis Child       Date:  1964-04

6.  Deferoxamine and diethylenetriaminepentaacetic acid (DTPA) in thalassemia.

Authors:  R McDonald
Journal:  J Pediatr       Date:  1966-10       Impact factor: 4.406

  6 in total
  3 in total

1.  Long-term administration of desferrioxamine in thalassaemia major.

Authors:  R Seshadri; J H Colebatch; P Gordon; H Ekert
Journal:  Arch Dis Child       Date:  1974-08       Impact factor: 3.791

2.  Urinary iron excretion in thalassaemia after desferrioxamine administration.

Authors:  R Seshadri; J H Colebatch; R Fisher
Journal:  Arch Dis Child       Date:  1974-03       Impact factor: 3.791

3.  Innovation for rare diseases and bioethical concerns: A thin thread between medical progress and suffering.

Authors:  Alberto Tommasini; Andrea Magnolato; Irene Bruno
Journal:  World J Clin Pediatr       Date:  2018-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.